ReviewFrontiers in endocrinology2024

Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe.

Maria Eleni Chondrogianni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.